Anti-Human LGALS8 Antibody
Anti-Human LGALS8 Antibody with collaborator-tested evidence for IHC. Read more ›
["IHC"]Product Description
LGALS8 is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Rabbit; clonality: Polyclonal; isotype: IgG; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for IHC. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Recombinant protein of human LGALS8; purification: Affinity purification; concentration: 0.4 mg/mL.
Database references: UniProt: O00214 | NCBI Gene: 3964.
Research Use Only.
Key Facts
| Target | LGALS8 |
| Also known as | Gal 8, Gal-8, Gal8, Galectin-8, LEG8, LGAL S8, Lectin galactoside binding soluble 8, Lgals8, PCTA 1, PCTA-1, PCTA1, Po66 CBP, Po66 carbohydrate binding protein, Po66 carbohydrate-binding protein, Po66-CBP, Prostate carcinoma tumor antigen 1, galectin-8g |
| Concentration | 0.4 mg/mL |
| Species reactivity | Human |
| Shelf life | 12 months from shipping dates |
| Research area | Cancer, Immunology |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | IHC | |
|---|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.